Profile
Presently, Klaus Henning Jensen is Chief Medical Officer for Vifor Pharma AG. In the past Dr. Jensen occupied the position of Therapeutic Area Head & Diabetes Development at Sanofi. Dr. Jensen received a doctorate from the University of Copenhagen and an MBA from Copenhagen Business School.
Former positions of Klaus Jensen
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 2019-11-30 |
| NOVO NORDISK A/S | General Counsel | - |
| VIFOR PHARMA | Chief Tech/Sci/R&D Officer | - |
Training of Klaus Jensen
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| SANOFI | Health Technology |
| Private companies | 1 |
|---|---|
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Klaus Jensen
